Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
NCT05237505Phase 2Recruiting
- Sponsor
- University of California, San Diego
- Start
- Feb 2024
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in overlap syndrome (2 arms), sponsored by University of California, San Diego. Primary endpoints: Right ventricular mass at 6 months, Reactive Hyperemia Index at 6 months and 2 more. Started Feb 2024; status: recruiting.
02
Conditions
overlap syndrome
Beyond the preview
Go deeper on NCT05237505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05237505.